Quinoline‐linked 1,2,3‐Triazole Hybrids: Design, Synthesis, Anticancer Activity and Computational Investigations
Chemistry & Biodiversity · 14.04.2025
DOI: 10.1002/cbdv.202403184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 14.04.2025. Verfasst von Rambabu Bhukya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University College of Science, Osmania University, Hyderabad, India. Hauptthemen laut MEDLINE: Triazoles, Antineoplastic Agents, Quinolines, Drug Design. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Synthesized a library of new quinoline‐based 1,2,3‐triazole scaffolds involving Suzuki‐Miyaura cross‐coupling and metal‐free multicomponent reactions. Evaluated their in vitro anticancer activities against human breast (MCF‐7), lung (A‐549) and liver (HepG2) cancer cell lines with reference to Doxorubicin as standard. Four compounds 5a , 5d , 5e and 5f displayed outstanding activity against all three cell lines. Compound 5a , showcasing ‐Cl in the R 2 position of the phenyl ring demonstrated potent activity with IC 50 values of 9.25 ± 0.22 , 9.56 ± 0.19 and 10.56 ± 0.19 µM against MCF‐7, A‐549 and HepG2 cell lines respectively. The compound 5f , containing m −Cl and m ‐OMe groups in R 1 and R 2 positions demonstrated potent activity with IC 50 values of 10.49 ± 0.31 (MCF‐7), 10.27 ± 0.27 (A‐549) and 11.27 ± 0.30 µM (HepG2). Compound 5f with −Cl and −I group presented potent activity with an IC 50 value of 11.40 ± 0.29 (MCF‐7), 10.42 ± 0.21 (A‐549) and 12.32 ± 0.33 µM (HepG2). Compound 5d gave out a potent activity with IC 50 values of 10.42 ± 0.25 (MCF‐7), 12.97 ± 0.22 (A‐549) and 13.05 ± 0.45 µM (HepG2). Toxicity results against Hek‐293 proved that these compounds were not harmful. The computational screening of these compounds revealed favourable drug‐likeness properties and important binding interactions against Fibroblast Growth Factor Receptor 1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University College of Science, Osmania University, Hyderabad, India.
- Department of Sciences and Humanities, Matrusri Engineering College, Hyderabad, India.
ORCID-Profile: Vishnu Thumma, Ramchander Jadhav
Zitieren
APA
Bhukya, R., Vanga, M. K., Bhukya, C., Thumma, V., & Jadhav, R. (2025). Quinoline‐linked 1,2,3‐Triazole Hybrids: Design, Synthesis, Anticancer Activity and Computational Investigations. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202403184
Vancouver
Bhukya R, Vanga MK, Bhukya C, Thumma V, Jadhav R. Quinoline‐linked 1,2,3‐Triazole Hybrids: Design, Synthesis, Anticancer Activity and Computational Investigations. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202403184
BibTeX
@article{Bhukya2025,
author = {Bhukya, Rambabu and Vanga, Murali Krishna and Bhukya, Chandulal and Thumma, Vishnu and Jadhav, Ramchander},
title = {Quinoline‐linked 1,2,3‐Triazole Hybrids: Design, Synthesis, Anticancer Activity and Computational Investigations},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202403184}
}
EUVIMED